Profile
| Role | Insider |
|---|---|
| Notability | 30/100 |
Updated Jul 16, 2026
Stueland Katherine has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $16.70M.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 2.4K | $61.50 | $149K |
| 2026-06-18 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 5.9K | $60.83 | $361K |
| 2026-06-18 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 2.1K | $59.75 | $128K |
| 2026-06-18 | WGS | GeneDx Holdings Corp. | M — Option exercise | 18.8K | $0.00 | |
| 2026-06-11 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 3.6K | $53.77 | $196K |
| 2026-06-11 | WGS | GeneDx Holdings Corp. | M — Option exercise | 6.5K | $0.00 | |
| 2026-05-01 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 18 | $64.12 | $1K |
| 2026-05-01 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 2.2K | $65.20 | $140K |
| 2026-05-01 | WGS | GeneDx Holdings Corp. | M — Option exercise | 3.9K | $0.00 | |
| 2026-03-30 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 9.9K | $65.21 | $645K |
| 2026-03-30 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 5.3K | $64.60 | $342K |
| 2026-03-30 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 13.4K | $63.28 | $849K |
| 2026-03-30 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 5.1K | $62.33 | $319K |
| 2026-03-30 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 13.2K | $61.29 | $811K |
| 2026-03-30 | WGS | GeneDx Holdings Corp. | M — Option exercise | 80.0K | $0.00 | |
| 2026-03-17 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 772 | $77.94 | $60K |
| 2026-03-17 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 9.2K | $77.05 | $711K |
| 2026-03-17 | WGS | GeneDx Holdings Corp. | S — Open-market sale | 7.2K | $76.35 | $548K |
| 2026-03-17 | WGS | GeneDx Holdings Corp. | M — Option exercise | 18.8K | $0.00 | |
| 2026-03-17 | WGS | GeneDx Holdings Corp. | M — Option exercise | 11.9K | $0.00 |
Stueland Katherine is a corporate insider — currently tracked as Insider of GeneDx Holdings Corp. (WGS). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 51 open-market sales ($16.70M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Stueland Katherine profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.